| Company Name | Fiscal Year | EPS (Estimated) | Revenue (Estimated) | Exchange | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Thursday - Dec 03, 2026 |
|||||||||
| Q3 FY26 | $1.16 | $34.57B | |||||||
| Q4 FY26 | $1.27 | $14.35B | |||||||
| Q3 FY26 | $1.39 | $11.14B | |||||||
|
Hormel Foods
HRL
|
Q4 FY26 | $0.38 | $3.17B |
NYSE |
|||||
| Q3 FY26 | $5.60 | $2.99B | |||||||
|
Science Applications International
SAIC
|
Q3 FY27 | $2.33 | $1.82B |
NASDAQ |
|||||
|
The Cooper Companies
COO
|
Q4 FY26 | $1.07 | $1.07B |
NASDAQ |
|||||
|
Brown-Forman
BF-A
|
Q2 FY27 | $0.46 | $1.04B |
NYSE |
|||||
|
Donaldson
DCI
|
Q1 FY27 | $0.97 | $1.02B |
NYSE |
|||||
| Q3 FY27 | $1.17 | $889.02M | |||||||
|
Hovnanian Enterprises
HOV
|
Q4 FY26 | $2.80 | $826M |
NYSE |
|||||
|
Genesco
GCO
|
Q3 FY27 | $0.94 | $597.70M |
NYSE |
|||||
| Q3 FY27 | $0.19 | $515.22M | |||||||
|
John Wiley & Sons
WLY
|
Q2 FY27 | $1.24 | $448M |
NYSE |
|||||
| Q3 FY27 | $0.09 | $429.65M | |||||||
|
Guidewire Software
GWRE
|
Q1 FY27 | $0.75 | $376.40M |
NYSE |
|||||
|
Argan
AGX
|
Q3 FY27 | $3.14 | $358.78M |
NYSE |
|||||
|
Sportsman's Warehouse Holdings
SPWH
|
Q3 FY26 | $0.12 | $331.55M |
NASDAQ |
|||||
|
IDT
IDT
|
Q1 FY27 | $1.03 | $331M |
NYSE |
|||||
|
Stitch Fix
SFIX
|
Q1 FY27 | -$0.07 | $326.20M |
NASDAQ |
|||||
|
SentinelOne
S
|
Q3 FY27 | $0.09 | $310.17M |
NYSE |
|||||
|
National Beverage
FIZZ
|
- | $0.48 | $304.19M |
NASDAQ |
|||||
|
ServiceTitan
TTAN
|
Q3 FY27 | $0.26 | $286.52M |
NASDAQ |
|||||
|
Zumiez
ZUMZ
|
Q3 FY26 | $0.07 | $224.48M |
NASDAQ |
|||||
|
REX American Resources
REX
|
Q3 FY26 | $0.53 | $206.55M |
NYSE |
|||||
|
Smith & Wesson Brands
SWBI
|
Q2 FY27 | $0.09 | $136.48M |
NASDAQ |
|||||
|
Lee Enterprises
LEE
|
Q4 FY26 | $0.06 | $125.51M |
NASDAQ |
|||||
|
Build-A-Bear Workshop
BBW
|
Q3 FY26 | $0.45 | $117.95M |
NYSE |
|||||
|
ChargePoint Holdings
CHPT
|
Q3 FY27 | -$0.55 | $110.77M |
NYSE |
|||||
|
Domo
DOMO
|
Q2 FY27 | $0.01 | $77.87M |
NASDAQ |
|||||
|
Lakeland Industries
LAKE
|
Q3 FY27 | $0.03 | $50.52M |
NASDAQ |
|||||
|
KalVista Pharmaceuticals
KALV
|
Q2 FY26 | -$0.29 | $48.66M |
NASDAQ |
|||||
| Show 22 more companies | |||||||||
